Vagelos P Roy - Mar 30, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Stock symbol
REGN
Transactions as of
Mar 30, 2022
Transactions value $
-$20,000,686
Form type
4
Date filed
4/1/2022, 04:08 PM
Previous filing
Mar 15, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$10M -14.3K -10.11% $700.02 127K Mar 30, 2022 by CLAT F1, F2
transaction REGN Common Stock Sale -$10M -14.3K -37.85% $700.00 23.5K Mar 30, 2022 by Spouse as Trustee F1, F3
holding REGN Common Stock 346K Mar 30, 2022 Direct
holding REGN Common Stock 2.1K Mar 30, 2022 By 401(k) Plan
holding REGN Common Stock 3.61K Mar 30, 2022 by trust for grandch F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price.
F4 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.